Sign inJoin waitlistJoin the waitlist

Samer Khaled

Hematologist-Oncologist · City of Hope National Medical Center

Credentials: · · · · ·

History

Sutter Health Valley Area
2025–Present

Hematology
2001–2002
Internal Medicine
1998–2001
Doctor of Medicine
1994–1998

Research

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
The Lancet Oncology · 2019 · 402 citations
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Blood · 2016 · 275 citations
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant
American Journal of Hematology · 2018 · 107 citations

Stephen Forman
34 papers
Guido Marcucci
31 papers
Ryotaro Nakamura
29 papers
Ibrahim Aldoss
27 papers
AS
Anthony Stein
25 papers
AS
Amandeep Salhotra
23 papers
Haris Ali
23 papers
VP
Vinod Pullarkat
23 papers
Ahmed Aribi
21 papers
Monzr Al Malki
20 papers · 1 as a fellow
DS
David Snyder
18 papers
KS
Karamjeet Sandhu
16 papers

Clinical trials

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Principal investigator · Active not recruiting · Phase 2
City of Hope Medical Center
2014–2026
Expanded Access Program for OOS Obe-cel
Site PI · Available
Autolus Limited